ResMed Inc. (N:RMD)

Business Focus: Advanced Medical Equipment & Technology

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for RMD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 4th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 2/20 Dec 1/20 Sodhi Rajwant Direct Ownership ResMed Common Stock S - Open market or private sale -1,500 $210.46
Dec 1/20 Dec 1/20 Hollingshead James Direct Ownership ResMed Common Stock S - Open market or private sale -2,400 $210.97
Nov 30/20 Nov 27/20 Gill Harjit Direct Ownership ResMed Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -116 $212.11
Nov 30/20 Nov 27/20 De Witte Jan Direct Ownership ReMed Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -183 $212.11
Nov 25/20 Nov 24/20 Sandercock Brett Direct Ownership ResMed Common Stock S - Open market or private sale -5,000 $211.00
Nov 25/20 Nov 24/20 Douglas Robert Andrew Indirect Ownership ResMed Common Stock G - Gift -478  
Nov 25/20 Nov 24/20 Douglas Robert Andrew Indirect Ownership ResMed Common Stock S - Open market or private sale -955 $211.00
Nov 24/20 Nov 23/20 Pendarvis David Direct Ownership ResMed Common Stock G - Gift -10,000  
Nov 24/20 Nov 20/20 Pendarvis David Direct Ownership ResMed Common Stock Options M - Exercise or conversion exempt under rule 16b-3 -1,176  
Nov 24/20 Nov 20/20 Pendarvis David Direct Ownership ResMed Common Stock M - Exercise or conversion exempt under rule 16b-3 1,176 $84.98
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for RMD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 4th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 2/20 Dec 1/20 Sodhi Rajwant Direct Ownership ResMed Common Stock S - Open market or private sale -1,500 $210.46
Dec 1/20 Dec 1/20 Hollingshead James Direct Ownership ResMed Common Stock S - Open market or private sale -2,400 $210.97
Dec 1/20 Nov 19/20 Douglas Robert Andrew Direct Ownership ResMed Common Stock Options A - Grant, award or other under Rule 16b-3(d) 20,776  
Dec 1/20 Nov 19/20 Drexler Karen Direct Ownership ResMed Common Stock Options A - Grant, award or other under Rule 16b-3(d) 2,308  
Dec 1/20 Nov 19/20 Drexler Karen Direct Ownership ResMed Common Stock A - Grant, award or other under Rule 16b-3(d) 594  
Dec 1/20 Nov 19/20 Pendarvis David Direct Ownership ResMed Common Stock Options A - Grant, award or other under Rule 16b-3(d) 7,849  
Nov 30/20 Nov 27/20 Gill Harjit Direct Ownership ResMed Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -116 $212.11
Nov 30/20 Nov 19/20 Burt Carol Direct Ownership ResMed Common Stock A - Grant, award or other under Rule 16b-3(d) 1,187  
Nov 30/20 Nov 27/20 De Witte Jan Direct Ownership ReMed Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -183 $212.11
Nov 25/20 Nov 24/20 Sandercock Brett Direct Ownership ResMed Common Stock S - Open market or private sale -5,000 $211.00
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $RMD

Competitors

Competitors with Recent Insider Filings
Danaher (N:DHR)
Thermo Fisher Scientific (N:TMO)
Edwards Lifesciences (N:EW)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.